Bioventus Inc. revenue for the last year amounted to 512.35 M USD, the most of which — 220.80 M USD — came from its highest performing source at the moment, Pain Treatments, the year earlier bringing 216.32 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Bioventus Inc. 449.86 M USD, and the year before that — 455.25 M USD.